Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015

Date: May 22, 2011
Pages: 692
Price:
US$ 4,710.00
License [?]:
Publisher: Axis Research Mind
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CACD6F7BD9BEN
Leaflet:

Download PDF Leaflet

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015
GLOBAL MARKET WATCH:

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. The major application use in stem cells market is classified into oncology, cardiology, and bone & cartilage. Among the applications areas, neurology is forecasts to exert highest support to the stem cells market growth with a CAGR of 24.4% during 2010-2015. Hematology and diabetes are expected to lead the stem cell market during 2010-2015. Our study on the stem cell technologies reveals that cord blood banking and xenotransplantation are expected to lead the technologies during 2010-2015. Drug discovery and stem cell transplantation techniques are also expected to ground in the upcoming years.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.

Improving health consciousness in Europe will likely maintain the Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.

New trends in stem cell technologies realized multidisciplinary research consortia among academic, medical, government and industry partners. Anticipating a boom in technological space, the consortia members are expected to be benefitted in the application front and in practicing stem-cell technology in life science arena.

Report Focus:

The ‘Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies – A Global Market Watch, 2009-2015’ reviews the latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
  • Latest Market Trends
  • Key Competitors Edge
  • Investment Strategies
  • Stem cell market trends in emerging markets
  • Advancements in the technological space
  • Demand of the market segments (by-region)
  • Key growth areas and market size

The report delivers a microscopic overview of major product segments, applications and technological areas of stem cells market, regionally. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others.

The major stem cells applications areas discussed in the report are:
  • Bone & Cartilage
  • Cardiac
  • Skin
  • Diabetes
  • Blood Disorders
  • Neuro
  • Cancer
  • Digestive System
  • Drug Development
  • Eyes
  • Injuries
  • Reproductive System and
  • Others

The major stem cells technologies discussed in the report are:
  • Cell Based Technologies
  • Cord Blood Banking
  • Cryopreservation
  • Stem Cell Banking
  • Stem Cell Characterization
  • Stem Cell Drug Discovery
  • Stem Cell Production
  • Stem Cell Transplants
  • Xenotransplantation and
  • Others (Blood Transfusion and Molecular Biology and Others)

The report focuses on the major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the near future are profiled. The report consists of 508 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific); Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases and published research reports are also used for estimates. Estimates have incorporated recessionary impact on the Stem Cells industry.

Some companies mentioned out of 500 companies:

AASTROM BIOSCIENCES, INC.
ACORDA THERAPEUTICS, INC.
ADVANCED CELL TECHNOLOGY, INC.
AFFYMETRIX, INC
ALPHA CORD, INC
ANGIOBLAST SYSTEMS, INC.
BIOHEART, INC
BOEHRINGER-INGELHEIM GMBH
CELL THERAPEUTICS, INC.
CELLS4LIFE LTD.
CORCELL, INC.
CORD BLOOD REGISTRY
CORDLIFE LTD.
CRYOCORD SDN. BHD.
And many more…………
I. REPORT FOCUS

A. INTRODUCTION
  FUNCTIONS OF STEM CELLS
  STEM CELL APPLICATIONS
  STEM CELL MILESTONES
  DEFINITION AND IMPORTANCE
  STEM CELL DEBATE
  CONCLUSION
B. STEM CELLS – THE BEGINNING OF ALL BLOOD CELLS
  ADULT STEM CELLS
  EMBRYONIC STEM CELLS
  UMBILICAL CORD BLOOD STEM CELLS
  TOTIPOTENT STEM CELLS
  PLURIPOTENT STEM CELLS
  MULTIPOTENT STEM CELLS
  OLIGOPOTENT STEM CELLS
  UNIPOTENT STEM CELLS
  INDUCED PLURIPOTENT STEM CELLS (IPSCS)
  DISEASE DETECTION
  CHALLENGES TO CULTURE
  STANDARD GUIDELINE FOR IPS TECHNOLOGY
C. ADVANCES IN STEM CELL RESEARCH
D. SIMILARITIES AND DIFFERENCES BETWEEN EMBRYONIC AND ADULT STEM CELLS
E. THE CONTROVERSY ON STEM CELL
  STEM CELLS BACKGROUND
  OUTLOOK
  ARGUMENT
  PROPER USE
  TRANSCENDENCE
  THE BEGINNING
  LIFE IMPORTANCE
F. A REVIEW ON ADULT STEM CELLS
  THE ROLE OF ADULT STEM CELLS IN TISSUE REPAIR
  ADULT STEM CELLS AND CANCER
  FIRST TRANSPLANTATION OF HUMAN ORGAN GROWN FROM ADULT STEM CELLS
  ADVANTAGES OF ADULT BM CELLS TRANSPLANTATION IN CARDIOLOGY
  CONCLUSION
G. A REVIEW ON EMBRYONIC STEM CELLS
  HISTORY
  MAJOR SUPPORT TO EMBRYONIC STEM CELL RESEARCH
  A COMBINED EFFORT
  CONFUSING LEGISLATION
  REWARDING THE DESERVING
  GOVERNMENTAL POLICY IN DIFFERENT REGIONS
  AMERICANS
  UNITED STATES
  EUROPE
  ASIA-PACIFIC
  AFRICA
  EMBRYONIC STEM CELL RESEARCH “CONTROVERSY”
  CREATION OF EMBRYONIC CHARACTERISTICS FROM HUMAN UMBILICAL CORD BLOOD
  HUMAN EMBRYONIC STEM CELLS (HES) CLASSIFICATION AND DIFFERENTIATION
  ORIGIN, EXPANSION AND APPLICATIONS OF HUMAN EMBRYONIC STEM CELLS
  ADVANTAGES OF ES CELL TRANSPLANTATION IN CARDIOLOGY
H. A REVIEW ON CORD BLOOD STEM CELLS
  ENHANCEMENTS
  USES OF CORD BLOOD BANKING
  FOCUS AND SCOPE OF COMPANIES INTO CORD BLOOD STEM CELLS
  BMSN (BIO-MATRIX SCIENTIFIC GROUP, INC.)
  MEDISTEM INC.
  CRYO-CELL INTERNATIONAL, INC.
  GLANCE AT U.S PRIVATE FAMILY BANKS
  CORD BLOOD AMERICA, INC.
  VIACELL, INC.
  OTHER COMPANIES
  PROGRESS IN CORD BLOOD COLLECTION, PROCESSING AND TRANSPLANTATION
  TIGHT MEASURES AND CERTIFICATIONS
  TEST ON STEM CELLS FROM BLOOD CORD
I. ROLE OF STEM CELLS IN VARIOUS APPLICATIONS
  ROLE OF STEM CELLS IN BONE & CARTILAGE
  CURRENT DEVELOPMENTS
  REPAIR OF CARTILAGE AND BONE WITH STEM CELLS
  ROLE OF ADULT STEM CELLS IN BONE AND CARTILAGE TISSUE ENGINEERING
  CARTILAGE AND BONE REBUILDING
  ROLE OF STEM CELLS IN CARDIAC
  BACKGROUND
  INTRODUCTION
  ADULT CARDIAC STEM (ACS) CELLS
  MARKERS OF STEM CELL-DERIVED CARDIOMYOCYTE DIFFERENTIATION
  MYOCARDIAL TRANSPLANTS: ADVANTAGES AND LIMITATIONS ASSOCIATED
  WITH DIFFERENT CELL-TYPES
  ROLE OF STEM CELLS IN SKIN
  UNDERSTANDING CELL TYPES
  SOMATIC STEM CELLS IN DERMATOLOGY
  STEM CELLS AND THEIR OFFSPRING ARRANGEMENT IN HUMAN EPIDERMIS
  SCLERODERMA PATIENTS GAIN FROM STEM CELL THERAPY
  ROLE OF STEM CELLS IN DIABETES
  STEM CELLS 'CURE DIABETES'
  DIABETES STEM-CELL TREATMENT LOOKS TO CELL CAPSULES
  GROWTH OF CELL-BASED THERAPIES FOR DIABETES
  FUTURE OF DIABETES WITH STEM CELLS THERAPY
  ROLE OF STEM CELLS IN BLOOD DISORDERS
  HEMATOPOIETIC BEGINNING OF HEPATIC STELLATE CELLS IN THE MATURE LIVER
  TIME FROM ANALYSIS TO CURING COMMENCEMENT FORETELL SURVIVAL IN YOUNGER AND NOT OLDER,
  SEVERE MYELOID LEUKEMIA PATIENTS
  ENDURING PRESERVATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS BY
  APPEARANCE OF BMI1
  SIGNALING PATHWAYS GOVERNING STEM-CELL FATE
  HEMATOLOGICAL EFFECT OF STEM CELL FACTOR (IN-VIVO AND IN-VITRO) ON RATS
  IS FAT TISSUE A RESOURCE OF PRICELESS BLOOD STEM CELLS?
  ROLE OF STEM CELLS IN NEURO
  STEM CELLS PROGRESS FOR THE CURE OF NEUROLOGICAL DISORDERS
  USAGE OF STEM CELLS IN NEUROLOGICAL DISEASES (HOPE OR HYPE)
  STEM CELLS APPLIED IN NERVOUS SYSTEM REPAIR
  STEM CELLS ACT THROUGH VARIOUS METHODS TO BENEFIT MICE WITH NEURODEGENERATIVE ILLNESS
  ROLE OF STEM CELLS IN CANCER
  OPTION OF RESOURCE OF STEM CELLS FOR CANCER THERAPY
  CANCER STEM CELLS AND ONCOLOGY THERAPEUTICS
  CANCER STEM CELL SUGGESTION IN THYROID CANCER
  FUTURE POTENTIALS
J. STEM CELLS TECHNOLOGY
  AUTOMATED STEM CELL CULTURE WITH GREATER CONSISTENCY
  RESTRICTIONS OBSERVED IN THE MANUAL CULTIVATION
  AUTOMATION SOLUTION
  CONSISTENCY AND REPRODUCIBILITY
K. STEM CELLS IN VARIOUS TECHNOLOGIES
  CELL BASED TECHNOLOGIES
    A) HEART DISEASE OR AILMENT
    B) DIABETES
    C) STEM CELL THERAPY OR TREATMENT FOR DIABETES
    D) PARKINSON'S DISEASE
  CORD BLOOD BANKING
  PUBLIC BANKS
  PRIVATE BANKS
  CRYOPRESERVATION
  STEM CELL BANKING
  STEM CELL CHARACTERIZATION
  STEM CELL DRUG DISCOVERY
  EMBRYONIC STEM CELLS AS A SOURCE OF MODELS FOR DRUG DISCOVERY
  STEM CELL PRODUCTION
  NEW WAY OF PRODUCING STEM CELLS FOUND
  STEM CELL TRANSPLANTS
  XENOTRANSPLANTAION
  BLOOD TRANSFUSION
  MOLECULAR BIOLOGY

II. MARKET ANALYSIS

STEM CELLS MARKET AND APPLICATIONS – SNAPSHOT

A. STEM CELLS MARKET AND APPLICATIONS – SEGMENTATION
B. STEM CELLS – BY COUNTRY
  NORTH AMERICA
  EUROPE
  ASIA-PACIFIC
  LATIN AMERICA
  REST OF WORLD
C. STEM CELLS – PRODUCT SEGMENTS
  C1. STEM CELL PRODUCT SEGMENTS - GEOGRAPHIC REGION
    ADULT STEM CELLS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  CORD BLOOD STEM CELLS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  EMBRYONIC STEM CELLS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  OTHER STEM CELLS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  C2. STEM CELLS – BY PRODUCT
    NORTH AMERICA
    THE USA
    CANADA
    MEXICO
  EUROPE
    BELGIUM
    DENMARK
    FRANCE
    GERMANY
    GREECE
    SPAIN
    SWEDEN
    THE UNITED KINGDOM
    REST OF EUROPE
  ASIA-PACIFIC
    AUSTRALIA
    CHINA
    INDIA
    JAPAN
    SOUTH KOREA
    REST OF ASIA-PACIFIC
  LATIN AMERICA
    ARGENTINA
    BRAZIL
  REST OF WORLD
    COLUMBIA
    MIDDLE EAST
    SOUTH AFRICA
    REST OF REST OF THE WORLD
D. STEM CELLS - APPLICATIONS
  STEM CELL - APPLICATIONS - GEOGRAPHIC REGION
  BONE & CARTILAGE
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  CARDIAC
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  SKIN
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  DIABETES
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  BLOOD DISORDERS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  NEURO
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  CANCER
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  OTHERS*
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  DIGESTIVE SYSTEM
    DRUG DEVELOPMENT
    EYES
    INJURIES
    REPRODUCTIVE SYSTEM
    OTHERS
E. STEM CELLS - TECHNOLOGIES
STEM CELLS - TECHNOLOGIES - GEOGRAPHIC REGION
  CELL BASED TECHNOLOGIES
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  CORD BLOOD BANKING
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  CRYOPRESERVATION
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  STEM CELL BANKING
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  STEM CELL CHARACTERIZATION
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  STEM CELL DRUG DISCOVERY
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  STEM CELL PRODUCTION
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  STEM CELL TRANSPLANTS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
  XENOTRANSPLANTATION
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
    OTHERS
    NORTH AMERICA
    EUROPE
    ASIA-PACIFIC
    LATIN AMERICA
    REST OF WORLD
F. STEM CELLS – BY APPLICATION
  NORTH AMERICA
    THE USA
    CANADA
    MEXICO
  EUROPE
    BELGIUM
    DENMARK
    FRANCE
    GERMANY
    GREECE
    SPAIN
    SWEDEN
    THE UNITED KINGDOM
    REST OF EUROPE
  ASIA-PACIFIC
    AUSTRALIA
    CHINA
    INDIA
    JAPAN
    SOUTH KOREA
    REST OF THE ASIA-PACIFIC
  LATIN AMERICA
    ARGENTINA
    BRAZIL
  REST OF WORLD
    COLUMBIA
    MIDDLE EAST
    SOUTH AFRICA
    REST OF REST OF WORLD
G. STEM CELLS – BY TECHNOLOGIES
  NORTH AMERICA
    THE USA
    CANADA
    MEXICO
  EUROPE
    BELGIUM
    DENMARK
    FRANCE
    GERMANY
    GREECE
    SPAIN
    SWEDEN
    THE UNITED KINGDOM
    REST OF EUROPE
  ASIA-PACIFIC
    AUSTRALIA
    CHINA
    INDIA
    JAPAN
    SOUTH KOREA
    REST OF ASIA-PACIFIC
  LATIN AMERICA
    ARGENTINA
    BRAZIL
    COLUMBIA
    MIDDLE EAST
    SOUTH AFRICA
    REST OF WORLD
H. GROWTH RATE ANALYSIS
GLOBAL STEM CELLS PRODUCTS, APPLICATIONS AND TECHNOLOGIES GROWTH RATES
  STEM CELLS - PRODUCT SEGMENTS
    GLOBAL STEM CELLS PRODUCT SEGMENTS MARKET GROWTH RATES
    ADULT STEM CELLS
    CORD BLOOD STEM CELLS
    EMBRYONIC STEM CELLS
  STEM CELLS - APPLICATIONS
    GLOBAL STEM CELL APPLICATIONS MARKET GROWTH RATES
    BONE & CARTILAGE
    CARDIAC
    SKIN
    DIABETES
    BLOOD DISORDERS
    NEURO
    CANCER
    DIGESTIVE SYSTEM
    DRUG DEVELOPMENT
    EYES
    INJURIES
    REPRODUCTIVE SYSTEM
  STEM CELL - TECHNOLOGIES
    GLOBAL STEM CELL TECHNOLOGIES MARKET GROWTH RATES
    CORD BLOOD BANKING
    STEM CELL CHARACTERIZATION
    XENOTRANSPLANTATION
    STEM CELL DRUG DISCOVERY
    STEM CELL TRANSPLANTS
    STEM CELL PRODUCTION
    STEM CELL BANKING
    CRYOPRESERVATION
    CELL BASED TECHNOLOGIES
F. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. INDUSTRY ACTIVITIES
  MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/etc……
  SPECIAL HUMAN CELLS DERIVED FROM STEM CELLS RESTORE MOVEMENT IN RATS WITH SPINAL CORD INJURY
  ASTROCYTES DERIVED FROM HUMAN STEM CELLS IMPROVE THE LOCOMOTOR FUNCTIONS OF RATS WITH SPINAL CORD INJURY
  CORD BLOOD AMERICA PURCHASE OF CORD BLOOD STEM CELLS STORED BY REPRODUCTIVE GENERATIVE INSTITUTE AN ILLINOIS FIRM
  LIFESPAN OF BONE MARROW STEM CELLS PREDICTED THROUGH COMPUTER MODEL, SOLVES THE REGENERATIVE PROBLEMS
  RECENT STUDY REVEAL A COMBINATION OF CELLASTIM AND OPTIFERRIN IS IDEAL FOR STEM CELL EXPANSION WHICH REPLACES NEED OF BLOOD PRODUCTS
  SINGLE BLASTOMERE TECHNOLOGY SECURES PATENT TO GENERATE EMBRYONIC STEM CELLS ENSURING EMBRYO SAFETY
  MESENCHYMAL STEM CELLS TO IMPROVE THE DAMAGED CELLS AFTER HEART ATTACK
  STEMCELLS, INC. COMPLETES SECOND TRIAL OF HUCNS-SC(R) NEURAL STEM CELLS, A POTENTIAL TREATMENT FOR MYELINATION DISORDER
  AMNIOTIC FLUID COLLECTED DURING THIRD TRIMESTER IS A RELIABLE SOURCE OF STEM CELLS FOR REGENERATIVE MEDICINE AND STEM CELL BANKING
  CORD BLOOD AMERICA, INC. ANNOUNCES PURCHASE OF MINORITY INTEREST IN VIDAPLUS EXPECTED TO GAIN REVENUE AND POPULARITY IN EUROPE
  INDUCED PLURIPOTENT STEM CELLS ARE SAFER AND CANCEROUS GROWTH MAY BE AVOIDED
  MICRORNAS ENHANCES THE GENERATION OF INDUCED PLURIPOTENT STEM CELLS (IPS), THROUGH REPROGRAMMING SKIN STEM CELLS
  ROLE OF STEM CELLS IN REPAIRING DAMAGED HEART OF CHILDREN
  THE FRAUNHOFER INSTITUTE IS FOCUSED TO STUDY THE CELL THERAPEUTIC PROCESSES IN ORDER TO OFFER SUITABLE SOLUTIONS
  MIRNA THERAPEUTICS, INC. PUBLISH NEW DATA ON MIR-34 IN INHIBITING THE GROWTH OF CANCER CELLS
  BIOCELLS, INC., TO STORE DENTAL PULP STEM CELLS WHICH AIDS IN STIMULATING NEURAL CELLS AND A SOURCE OF REGENERATIVE MEDICINE
  NEOSTEM, INC.'S RECOMMENDED FOR THE FINANCIAL AWARD OF $1,700,000 TO DEVELOP VERY SMALL EMBRYONIC-LIKE STEM CELLS WHICH IS A POTENTIAL CURE FOR OSTEOPOROSIS FROM DEPARTMENT OF DEFENSE PEER REVIEWED MEDICAL RESEARCH PROGRAM
  BIOHEART REPORTS THE USE OF ADIPOSE DERIVED STEM CELLS IN CURING CRITICAL LIMB ISCHEMIA
  POSITION OF DNA IN STEM CELL TRANSPLANT SUCCESS & FUNDING
  THE CHEAPEST STEM CELL TRANSPLANT FROM INDIA
  HUMAN STEM CELLS CALLED PARTHENOGENETIC CELLS, WHICH ARE DEVELOPED BY UNFERTILIZED HUMAN EGGS-ETHICAL CONSIDERATIONS AND MEDICAL ADVANTAGES
  ADVANCED CELL TECHNOLOGY AND THE ROSLIN INSTITUTE ANNOUNCE AGREEMENT FOR STORAGE AND DISTRIBUTION OF EMBRYONIC STEM CELLS USING ACT'S BLASTOMERE TECHNOLOGY
  STEM CELL TECHNOLOGY - A BREAKTHROUGH IN GROWING FUNCTIONAL INTESTINE TISSUE
  ADVANCED CELL TECHNOLOGY CLEARED BY FDA FOR THE FIRST CLINICAL TRIAL ON USING RETINAL STEM CELLS FOR CURING STARGARDT’S MACULAR DYSTROPHY
  EHSI: STEM CELLS COULD HELP HEART ATTACK VICTIMS
  STEMCYTE, INC. RECEIVED TWO AWARDS TOTALING TO $488,950 FOR ADVANCED THERAPEUTIC APPLICATIONS OF UMBILICAL CORD BLOOD STEM CELLS FROM THE QUALIFYING THERAPEUTIC DISCOVERY PROJECT (QTDP)
  SHRINK NANOTECHNOLOGIES REVEALS VIDEOS OF STEMDISC450 PROTOTYPE, A DEVICE FOR GROWING HUMAN EMBRYONIC STEM CELLS
  X-BODY BIOSCIENCES AWARDED GRANT FOR THERAPEUTIC DISCOVERY PROJECT TARGETING METASTATIC TUMOR STEM CELLS
  STEM CELLS REPAIR DAMAGED SPINAL CORD TISSUE IN RATS
  ROCHE?S CELLAVISTA SYSTEM ENHANCES THE STUDY OF SELF RENEWAL OF EMBRYONIC STEM CELLS
  GERON ENTERS INTO A LICENSE AGREEMENT FOR PRODUCTION OF CHONDOCYTES FROM IPS
  GUIDED ADULT STEM CELLS CAN EFFECTIVELY REPAIR HEARTS
  NEW CULTURE DISH OVERCOMES THE LIMITATIONS IN HUMAN EMBRYONIC STEM CELL RESEARCH
  STEM CELL THERAPY A MAJOR ROLE FOR ACUTE LUNG DAMAGE IN MICE
  NEW APPROACH IN MEDICAL APPLICATION OF RESOURCEFUL AND PROTECTED PLURIPOTENT STEM CELLS FOR ENGENDERING
  REGENERATIVE STEM CELL TREATMENTS WITH PATIENTS HAVING CONGESTIVE HEART FAILURE BIOHEART THERAPIES
  STEM CELL MODULATOR PIPELINE WITH ACQUISITION OF FATE THERAPEUTICS WITH VERIO THERAPEUTICS
  SRU BIOSYSTEMS ANNOUNCES INTRODUCTION OF BIND(R) SCANNER FOR PRIMARY AND STEM CELL APPLICATIONS
  NEW PROGRESS DIRECTED TO A GET THROUGH PROCESS FOR EXTENDED MEDICAL APPLICATION OF MATURE STEM CELLS
  AGREEMENT FOR PATENT AND CULTIVATION OF PLURIPOTENT STEM CELLS
  APPLICATION ON CHEMOKINE TECHNOLOGY TO INCREASE EFFICACY OF TISSUE-SPECIFIC STEM CELL HOMING IN COPD TREATMENT
  TESTING OF RETINAL PIGMENT FROM HUMAN PARTHENOGENETIC STEM CELLS
  AUGMENTATION FEATURE HELP STEM CELL GROWTH: REGENERATION
  ADULT ALLOGENEIC MESENCHYMAL STEM CELLS TREATMENT FOR STROKE FROM STEMEDICA CELL TECHNOLOGIES, INC
  STEM CELL MANUFACTURING FOR STROKE AND CLINICAL TRIAL FROM RENEURON GROUP PLC
  PATENT GRAND FOR PLURIPOTENT RAT STEM CELLS AND GENETICALLY ENGINEERED RATS FOR STEMCELLS, INC.
  STEM CELLS BUILD NEW BLOOD VESSELS FOR THE TREATMENT PERIPHERAL ARTERIAL DISEASE
  PROPRIETARY ADULT STEM CELL LINES FORMATION
  THE SYNTHEMAX(TM) SURFACE FOR SCALABLE GROWTH OF HUMAN EMBRYO DEVELOPED BY GERON CORPORATION AND CORNING INCORPORATED.
  STEM CELL INNOVATIONS TO OFFER AGENNIX THE RESEARCH AND ASSAY SERVICES
  CARDIAC STEM CELL THERAPY PRESENTATION - BMT TANDEM MEET BY OSIRIS THERAPEUTICS
  STEM CELL THERAPY FOR CARDIAC DISEASES
  EFFECTIVE USE OF PROPRIETARY STEM CELLS IN THE TREATMENT OF CIRRHOSIS OF THE LIVER
  REGENOCYTE EFFECTIVELY CURES CARDIOMYOPATHY PATIENT USING INDIVIDUAL ADULT STEM CELLS
  LIMBS WITH PERIPHERAL ARTERIAL DISEASE CAN BE SAVED BY USING ADULT STEM CELLS
  GAMIDA CELL LTD. CONTINUATION OF RESEARCH ON STEMEX(R), A CORD BLOOD STEM CELL PRODUCT, FOR LEUKEMIA AND LYMPHOMA
  BIOHEART’S INNOVATION OF FIRST FDA GRANT CLINICAL TRIAL TO TEST CONGESTIVE HEART FAILURE FOR GENE-MODIFIED STEM CELL THERAPY
  FATE THERAPEUTICS GETS GRANT OF FIRST U.S. COPYRIGHT FOR INDUCED PLURIPOTENT STEM CELL EXPERTISE
  STEM CELL THERAPY INTERNATIONAL CORP. COMPLETELY AMALGAMATED WITH HISTOSTEM, CO., LTD.
  INDIA THE NEXT POTENTIAL STEM CELL MARKET - CORDLIFE
  ROMANIA STARTS ITS EARLIEST STEM CELL FRIENDLY CASE
  STEM CELL GROUP MAKES A SUBSTITUTE BONE PIECE
  NEW CORD BLOOD THERAPY! A NEW RAY OF HOPE FOR MANY THALASSEMIA AFFECTED PATIENTS.
  FLORIDA UNIVERSITY SCIENTISTS DISCOVER THAT BLOOD STEM CELLS CAN BE CHANGED TO VISUALIZATION CELLS
  DISSIMILARITY ESTABLISHED BETWEEN EMBRYONIC STEM CELLS AND REPROGRAMMED SKIN CELLS
  “BUSH’S STEM CELL RESTRICTIONS TO GO” SAYS PRESIDENT OBAMA
  OBAMA TO LIFT THE BAN IMPOSED BY BUSH ON EMBRYONIC STEM CELL RESEARCH
  INITIAL STEM CELL TEST GRANTED BY FDA
  A STEP FORWARD IN DIABETES TREATMENT DISCOVERED BY NOVOCELL
B. MARKET TRENDS
  STEM CELL TREATMENTS GIVE NEW EXPECTATION
  NEW METHOD FOUND TO OVERCOME IMMUNE SYSTEM REJECTION OF HUMAN EMBRYONIC STEM CELLS
  PLURIPOTENT STEM CELLS GENERATED FROM HORSES FOR THE FIRST TIME
  DARK CLOUDS OF UNCERTAINTIES LOOM OVER EMBRYONIC STEM CELL RESEARCH
  DONOR STEM CELL RESEARCH MAY REPAIR HEART DAMAGE
  HUMAN INDUCED PLURIPOTENT STEM CELLS SHOW MUTATION
  PREVALENT MUTATIONS FOUND IN REPROGRAMMED STEM CELLS
  ANTI-AGING INDUSTRY GOES FOR STEM CELL THERAPY
  STEM CELL TREATMENT TO CURE DIABETES
  REVOLUTIONARY STEM CELL REMEDY REINSTATES SIGHT
  UCLA STUDY REVEALS THE USE OF STEM CELLS TO DESTROY HIV
  STEM CELLS CAPABLE OF ASSISTING ANGINA PATIENTS
  AGREEMENT SKETCHING OUT MORAL APPROACH TO STEM CELL PLANNED
  HOTTEST DEVELOPMENTS IN STEM CELLS TREATMENTS
  EMBRYONIC STEM CELLS STUDY BEING TURNED INTO A CONTENTIOUS DISCUSSION
  ADULT STEM CELLS GROWING TO BE A HOPEFUL MARKET
  UNITED STATES ORTHOPEDIC STEM CELL FORECASTED TO GENERATE REVENUES WORTH $1.1 BILLION BY 2015
  HUMAN EXPERIMENTAL TEST OF STEM CELL BASED MEDICINE
  STEM CELLS CAPABLE OF REINSTATING MISPLACED BRAIN TASKS
  GROWING HEART VALVES FROM STEM CELLS
  STEM CELL TREATMENT COULD POSSIBLY WORK IN OPPOSITION TO BRAIN INFLAMMATION
  RESOURCEFUL STEM CELLS DISCOVERED IN AMNIOTIC FLUID
  STEM CELL PROGRESS BEING HIT BY TRADITIONALIST
C. INDUSTRY LEADERS
  AASTROM BIOSCIENCES, INC.
  BIOHEART, INC.
  CORD BLOOD REGISTRY
  CRYOLIFE, INC.
  OSIRIS THERAPEUTICS, INC.
  SIGMA-ALDRICH, CO.
  STEM CELL INNOVATIONS, INC.
  THERMO FISHER SCIENTIFIC, INC
  VIACORD
  RENEURON GROUP PLC
  CRYOCORD SDN. BHD
D. STEM CELLS MARKET – A LOOK A HEAD..!!
E. KEY COMPANY PROFILES
  NORTH AMERICA
  EUROPE
  ASIA-PACIFIC

V. APPENDIX

RESEARCH FOCUS
ABOUT AXIS RESEARCH MIND
DISCLAIMER
FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS
1. WORLDWIDE PRODUCT SEGMENTATION OF STEM CELLS MARKET
2. DIFFERENTIAL POTENTIAL RANGES FROM TOTIPOTENT STEM CELLS TO NULLIPOTENT CELLS
3. STEM CELLS BANKING STORAGE PRICE STRUCTURE AROUND THE WORLD
4. STEM CELLS COMPANIES IN DIFFERENT COUNTRIES WITH THEIR NUMBER OF TRANSPLANTS

II. MARKET ANALYSIS
A. STEM CELLS
5. GLOBAL STEM CELLS - SEGMENTATION BY PRODUCTS, APPLICATIONS AND TECHNOLOGIES
6. STEM CELLS – GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
7. STEM CELLS - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
8. STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

B. STEM CELLS – BY COUNTRY
9. STEM CELLS - USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
10. STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
11. STEM CELLS - BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
12. STEM CELLS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
13. STEM CELLS - AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
14. STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
15. STEM CELLS - ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
16. STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
17. STEM CELLS - COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
18. STEM CELLS - COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - % OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

C. STEM CELLS – PRODUCT SEGMENTS
19. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
20. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

ADULT STEM CELLS
21. STEM CELL PRODUCTS - ADULT STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
22. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
23. STEM CELL PRODUCTS - ADULT STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
24. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
25. STEM CELL PRODUCTS - ADULT STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
26. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
27. STEM CELL PRODUCTS - ADULT STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
28. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
29. STEM CELL PRODUCTS - ADULT STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
30. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
31. STEM CELL PRODUCTS - ADULT STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
32. STEM CELL PRODUCTS - ADULT STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

CORD BLOOD STEM CELLS
33. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
34. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
35. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
36. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
37. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
38. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
39. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
40. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
41. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
42. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
43. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
44. STEM CELL PRODUCTS - CORD BLOOD STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

EMBRYONIC STEM CELLS
45. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
46. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
47. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR USA AND CANADA - (2009-2015, IN USD$ MILLION)
48. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF USA AND CANADA MARKET VALUE - (2009 - 2012 - 2015)
49. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BELGIUM, DENMARK, FRANCE, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
50. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF BELGIUM, DENMARK, FRANCE, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
51. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
52. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
53. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BRAZIL - (2009-2015, IN USD$ MILLION)
54. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
55. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS - % OF MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

OTHER STEM CELLS
56. STEM CELL PRODUCTS - OTHER STEM CELLS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
57. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
58. STEM CELL PRODUCTS - OTHER STEM CELLS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
59. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
60. STEM CELL PRODUCTS - OTHER STEM CELLS FOR DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
61. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF DENMARK, FRANCE, GERMANY, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
62. STEM CELL PRODUCTS - OTHER STEM CELLS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
63. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
64. STEM CELL PRODUCTS - OTHER STEM CELLS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
65. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
66. STEM CELL PRODUCTS - OTHER STEM CELLS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
67. STEM CELL PRODUCTS - OTHER STEM CELLS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

C2. STEM CELLS – BY PRODUCT
NORTH AMERICA
68. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
69. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF NORTH AMERICAN MARKET VALUE - (2009 - 2012 - 2015)
70. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR THE UNITED STATES OF AMERICA - (2009-2015, IN USD$ MILLION)
71. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF THE UNITED STATES OF AMERICA MARKET VALUE - (2009 - 2012 - 2015)
72. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR CANADA - (2009-2015, IN USD$ MILLION)
73. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF CANADIAN MARKET VALUE - (2009 - 2012 - 2015)
74. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS FOR MEXICO - (2009-2015, IN USD$ MILLION)
75. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS - % OF MEXICAN MARKET VALUE - (2009 - 2012 - 2015)

EUROPE
76. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR EUROPE - (2009-2015, IN USD$ MILLION)
77. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF EUROPEAN MARKET VALUE - (2009 - 2012 - 2015)
78. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR BELGIUM - (2009-2015, IN USD$ MILLION)
79. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR DENMARK - (2009-2015, IN USD$ MILLION)
80. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF DANISH MARKET VALUE - (2009 - 2012 - 2015)
81. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR FRANCE - (2009-2015, IN USD$ MILLION)
82. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF FRENCH MARKET VALUE - (2009 - 2012 - 2015)
83. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS FOR GERMANY - (2009-2015, IN USD$ MILLION)
84. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS - % OF GERMAN MARKET VALUE - (2009 - 2012 - 2015)
85. STEM CELL PRODUCTS - EMBRYONIC STEM CELLS FOR GREECE - (2009-2015, IN USD$ MILLION)
86. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SPAIN - (2009-2015, IN USD$ MILLION)
87. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SPANISH MARKET VALUE - (2009 - 2012 - 2015)
88. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SWEDEN - (2009-2015, IN USD$ MILLION)
89. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SWEDISH MARKET VALUE - (2009 - 2012 - 2015)
90. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR THE UNITED KINGDOM - (2009-2015, IN USD$ MILLION)
91. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF THE UNITED KINGDOM MARKET VALUE - (2009 - 2012 - 2015)
92. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR REST OF EUROPE - (2009-2015, IN USD$ MILLION)
93. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)

ASIA-PACIFIC
94. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR ASIA-PACIFC - (2009-2015, IN USD$ MILLION)
95. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
96. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR AUSTRALIA - (2009-2015, IN USD$ MILLION)
97. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF AUSTRALIAN MARKET VALUE - (2009 - 2012 - 2015)
98. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR CHINA - (2009-2015, IN USD$ MILLION)
99. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF CHINESE MARKET VALUE - (2009 - 2012 - 2015)
100. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR INDIA - (2009-2015, IN USD$ MILLION)
101. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF INDIAN MARKET VALUE - (2009 - 2012 - 2015)
102. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR JAPAN - (2009-2015, IN USD$ MILLION)
103. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF JAPANESE MARKET VALUE - (2009 - 2012 - 2015)
104. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SOUTH KOREA - (2009-2015, IN USD$ MILLION)
105. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SOUTH KOREAN MARKET VALUE - (2009 - 2012 - 2015)
106. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
107. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)

LATIN AMERICA
108. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
109. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF LATIN AMERICAN MARKET VALUE - (2009 - 2012 - 2015)
110. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS FOR ARGENTINA - (2009-2015, IN USD$ MILLION)
111. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, AND OTHERS - % OF ARGENTINA MARKET VALUE - (2009 - 2012 - 2015)
112. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR BRAZIL - (2009-2015, IN USD$ MILLION)
113. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF BRAZILIAN MARKET VALUE - (2009 - 2012 - 2015)

REST OF WORLD
114. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
115. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)
116. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS FOR COLUMBIA - (2009-2015, IN USD$ MILLION)
117. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS AND OTHERS - % OF COLUMBIAN MARKET VALUE - (2009 - 2012 - 2015)
118. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR MIDDLE EAST - (2009-2015, IN USD$ MILLION)
119. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF MIDDLE EAST MARKET VALUE - (2009 - 2012 - 2015)
120. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR SOUTH AFRICA - (2009-2015, IN USD$ MILLION)
121. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF SOUTH AFRICAN MARKET VALUE - (2009 - 2012 - 2015)
122. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS FOR REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
123. STEM CELL PRODUCTS - ADULT STEM CELLS, CORD BLOOD STEM CELLS, EMBRYONIC STEM CELLS AND OTHERS - % OF REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

D. STEM CELLS - APPLICATIONS
124. STEM CELL APPLICATIONS - BONE & CARTILAGE, CARDIAC, SKIN, DIABETES, BLOOD DISORDERS, NEURO, CANCER AND OTHERS* FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
125. STEM CELL APPLICATIONS - BONE & CARTILAGE, CARDIAC, SKIN, DIABETES, BLOOD DISORDERS, NEURO, CANCER AND OTHERS* - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)
126. STEM CELL APPLICATIONS – OTHERS* - DIGESTIVE SYETEM, DRUG DEVELOPMENT, EYES, INJURIES, REPRODUCTIVE SYSTEM AND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
127. STEM CELL APPLICATIONS - OTHERS* - DIGESTIVE SYETEM, DRUG DEVELOPMENT, EYES, INJURIES, REPRODUCTIVE SYSTEM AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

BONE & CARTILAGE
128. STEM CELL APPLICATIONS - BONE & CARTILAGE BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
129. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
130. STEM CELL APPLICATIONS - BONE & CARTILAGE FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
131. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
132. STEM CELL APPLICATIONS - BONE & CARTILAGE FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
133. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
134. STEM CELL APPLICATIONS - BONE & CARTILAGE FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
135. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
136. STEM CELL APPLICATIONS - BONE & CARTILAGE FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
137. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
138. STEM CELL APPLICATIONS - BONE & CARTILAGE FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
139. STEM CELL APPLICATIONS - BONE & CARTILAGE - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

CARDIAC
140. STEM CELL APPLICATIONS - CARDIAC BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
141. STEM CELL APPLICATIONS - CARDIAC - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
142. STEM CELL APPLICATIONS - CARDIAC FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
143. STEM CELL APPLICATIONS - CARDIAC - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
144. STEM CELL APPLICATIONS - CARDIAC FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
145. STEM CELL APPLICATIONS - CARDIAC - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
146. STEM CELL APPLICATIONS - CARDIAC FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
147. STEM CELL APPLICATIONS - CARDIAC - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
148. STEM CELL APPLICATIONS - CARDIAC FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
149. STEM CELL APPLICATIONS - CARDIAC - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
150. STEM CELL APPLICATIONS - CARDIAC FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
151. STEM CELL APPLICATIONS - CARDIAC - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

SKIN
152. STEM CELL APPLICATIONS - SKIN BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
153. STEM CELL APPLICATIONS - SKIN - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
154. STEM CELL APPLICATIONS - SKIN FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
155. STEM CELL APPLICATIONS - SKIN - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
156. STEM CELL APPLICATIONS - SKIN IN BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
157. STEM CELL APPLICATIONS - SKIN - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
158. STEM CELL APPLICATIONS - SKIN FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
159. STEM CELL APPLICATIONS - SKIN - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
160. STEM CELL APPLICATIONS - SKIN FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
161. STEM CELL APPLICATIONS - SKIN - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
162. STEM CELL APPLICATIONS - SKIN FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
163. STEM CELL APPLICATIONS - SKIN - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

DIABETES
164. STEM CELL APPLICATIONS - DIABETES BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
165. STEM CELL APPLICATIONS - DIABETES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
166. STEM CELL APPLICATIONS - DIABETES IN USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
167. STEM CELL APPLICATIONS - DIABETES - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
168. STEM CELL APPLICATIONS - DIABETES FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
169. STEM CELL APPLICATIONS - DIABETES - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
170. STEM CELL APPLICATIONS - DIABETES FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
171. STEM CELL APPLICATIONS - DIABETES - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
172. STEM CELL APPLICATIONS - DIABETES FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
173. STEM CELL APPLICATIONS - DIABETES - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
174. STEM CELL APPLICATIONS - DIABETES FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
175. STEM CELL APPLICATIONS - DIABETES - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

BLOOD DISORDERS
176. STEM CELL APPLICATIONS - BLOOD DISORDERS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
177. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
178. STEM CELL APPLICATIONS - BLOOD DISORDERS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
179. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
180. STEM CELL APPLICATIONS - BLOOD DISORDERS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
181. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
182. STEM CELL APPLICATIONS - BLOOD DISORDERS FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
183. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
184. STEM CELL APPLICATIONS - BLOOD DISORDERS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
185. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
186. STEM CELL APPLICATIONS - BLOOD DISORDERS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
187. STEM CELL APPLICATIONS - BLOOD DISORDERS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

NEURO
188. STEM CELL APPLICATIONS - NEURO BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
189. STEM CELL APPLICATIONS - NEURO - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
190. STEM CELL APPLICATIONS - NEURO FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
191. STEM CELL APPLICATIONS - NEURO - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
192. STEM CELL APPLICATIONS - NEURO FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
193. STEM CELL APPLICATIONS - NEURO - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
194. STEM CELL APPLICATIONS - NEURO FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
195. STEM CELL APPLICATIONS - NEURO - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
196. STEM CELL APPLICATIONS - NEURO FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
197. STEM CELL APPLICATIONS - NEURO - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
198. STEM CELL APPLICATIONS - NEURO FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
199. STEM CELL APPLICATIONS - NEURO - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

CANCER
200. STEM CELL APPLICATIONS - CANCER BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
201. STEM CELL APPLICATIONS - CANCER - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
202. STEM CELL APPLICATIONS - CANCER FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
203. STEM CELL APPLICATIONS - CANCER - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
204. STEM CELL APPLICATIONS - CANCER FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
205. STEM CELL APPLICATIONS - CANCER - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
206. STEM CELL APPLICATIONS - CANCER IN AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
207. STEM CELL APPLICATIONS - CANCER - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
208. STEM CELL APPLICATIONS - CANCER FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
209. STEM CELL APPLICATIONS - CANCER - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
210. STEM CELL APPLICATIONS - CANCER FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
211. STEM CELL APPLICATIONS - CANCER - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

OTHERS*
212. STEM CELL APPLICATIONS - OTHERS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
213. STEM CELL APPLICATIONS - OTHERS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
214. STEM CELL APPLICATIONS - OTHERS FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
215. STEM CELL APPLICATIONS - OTHERS - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
216. STEM CELL APPLICATIONS - OTHERS FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
217. STEM CELL APPLICATIONS - OTHERS - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
218. STEM CELL APPLICATIONS - OTHERS IN AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
219. STEM CELL APPLICATIONS - OTHERS - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
220. STEM CELL APPLICATIONS - OTHERS FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
221. STEM CELL APPLICATIONS - OTHERS - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
222. STEM CELL APPLICATIONS - OTHERS FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
223. STEM CELL APPLICATIONS - OTHERS - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

DIGESTIVE SYSTEM
224. STEM CELL APPLICATIONS - OTHERS - DIGESTIVE SYSTEM BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
225. STEM CELL APPLICATIONS - OTHERS - DIGESTIVE SYSTEM - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

DRUG DEVELOPMENT
226. STEM CELL APPLICATIONS - OTHERS - DRUG DEVELOPMENT BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
227. STEM CELL APPLICATIONS - OTHERS - DIGESTIVE SYSTEM - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

EYES
228. STEM CELL APPLICATIONS - OTHERS - EYES BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
229. STEM CELL APPLICATIONS - OTHERS - EYES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

INJURIES
230. STEM CELL APPLICATIONS - OTHERS - INJURIES BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
231. STEM CELL APPLICATIONS - OTHERS - INJURIES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

REPRODUCTIVE SYSTEM
232. STEM CELL APPLICATIONS - OTHERS - REPRODUCTIVE SYSTEM BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
233. STEM CELL APPLICATIONS - OTHERS - REPRODUCTIVE SYSTEM - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

OTHERS
234. STEM CELL APPLICATIONS - OTHERS - OTHERS BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
235. STEM CELL APPLICATIONS - OTHERS - OTHERS - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)

D. STEM CELLS - TECHNOLOGIES
236. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES, CORD BLOOD BANKING, CRYOPRESERVATION, STEM CELL BANKING, STEM CELL CHARACTERIZATION, STEM CELL DRUG DISCOVERY, STEM CELL PRODUCTION, STEM CELL TRANSPLANTS, XENOTRANSPLANTATION AND OTHERS FOR GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2009-2015, IN USD$ MILLION)
237. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES, CORD BLOOD BANKING, CRYOPRESERVATION, STEM CELL BANKING, STEM CELL CHARACTERIZATION, STEM CELL DRUG DISCOVERY, STEM CELL PRODUCTION, STEM CELL TRANSPLANTS, XENOTRANSPLANTATION AND OTHERS - % OF GLOBAL MARKET VALUE - (2009 - 2012 - 2015)

CELL BASED TECHNOLOGIES
238. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
239. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
240. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
241. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
242. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
243. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
244. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
245. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
246. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
247. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
248. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
249. STEM CELL TECHNOLOGIES - CELL BASED TECHNOLOGIES - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

CORD BLOOD BANKING
250. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
251. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE BY GEOGRAPHIC REGION - (2009 - 2012 - 2015)
252. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING FOR USA, CANADA AND MEXICO - (2009-2015, IN USD$ MILLION)
253. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF USA, CANADA AND MEXICO MARKET VALUE - (2009 - 2012 - 2015)
254. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING FOR BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
255. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF BELGIUM, DENMARK, FRANCE, GERMANY, GREECE, SPAIN, SWEDEN, UNITED KINGDOM AND REST OF EUROPE MARKET VALUE - (2009 - 2012 - 2015)
256. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING FOR AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
257. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF AUSTRALIA, CHINA, INDIA, JAPAN, SOUTH KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2009 - 2012 - 2015)
258. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING FOR ARGENTINA AND BRAZIL - (2009-2015, IN USD$ MILLION)
259. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF ARGENTINA AND BRAZIL MARKET VALUE - (2009 - 2012 - 2015)
260. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING FOR COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD - (2009-2015, IN USD$ MILLION)
261. STEM CELL TECHNOLOGIES - CORD BLOOD BANKING - % OF COLUMBIA, MIDDLE EAST, SOUTH AFRICA AND REST OF REST OF WORLD MARKET VALUE - (2009 - 2012 - 2015)

CRYOPRESERVATION
262. STEM CELL TECHNOLOGIES - CRYOPRESERVATION BY GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
263. STEM CELL TECHNOLOGIES - CRYOPRESERVATION - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD
Skip to top


Delving into Stem Cell Research and its Potential US$ 350.00 Jan, 2012 · 155 pages
Stem Cell Market: Opportunities and Challenges US$ 800.00 Dec, 2010 · 44 pages
US Stem Cell Market Analysis US$ 800.00 Apr, 2011 · 65 pages
The Stem Cell Market Outlook US$ 3,835.00 Jun, 2011 · 113 pages

Ask Your Question

Cord Blood, Embryonic and Adult Stem Cells Applications & Technologies - A Global Market Watch, 2009-2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: